SPECTRUM OF REACTIVITY WITH 3 MONOCLONAL-ANTIBODIES - MHM6(CD23), L30(CD24) AND UCHB1-IN B-CELL LEUKEMIAS

被引：6

作者：

BAIN, B ^{[1
]}

MORILLA, R ^{[1
]}

MONARD, S ^{[1
]}

KOKAI, Y ^{[1
]}

CATOVSKY, D ^{[1
]}

机构：

[1] ROYAL MARSDEN HOSP,ACAD DEPT HAEMATOL & CYTOGENET,FULHAM RD,LONDON SW3 6JJ,ENGLAND

来源：

LEUKEMIA & LYMPHOMA | 1990年 / 3卷 / 02期

关键词：

B-cell leukaemia; Leukaemia; Lymphoid leukaemia; Monoclonal antibody;

D O I：

10.3109/10428199009050982

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cells from patients with a range of B-cell leukaemias have been investigated for reactivity with three monoclonal antibodies-MHM6 (CD23), L30 (CD24) and UCHB1. Cells in suspension were studied by indirect immunofluorescence and fixed cells in cytospin preparations by an indirect immunoperoxidase technique. Positive results with CD23 were obtained in two thirds of patients with chronic lymphocytic leukaemia in contrast to one quarter of cases of other mature B-lineage leukaemias and lymphomas; cells of acute lymphoblastic leukaemia gave negative results. L30 (CD24) had a wide spectrum of reactivity within the B-lineage with negative reactions being common only in hairy cell leukaemia and multiple myeloma/plasma cell leukaemia. UCHB1 was most frequently and most strongly positive in prolymphocytic leukaemia. Our observations suggest that these reagents, in particular L30 (CD24) and MHM6 (CD23), provide useful additional information in the differential diagnosis of B-lineage lymphoproliferative disorders. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：97 / 102

页数：6

共 12 条

[1]

Nadler L.M., Reinherz E.L., Haynes B.F., Nadler L.M., Bernstein I.D., B cell/leukemia panel workshop

[2]

summary and comments, Leukocyte Typing II. Human B lymphocytes, pp. 3-43, (1985)

[3]

Ling N.R., Maclennan I.C.M., Mason D.Y., McMichael A.J., Leucocyte typing III White cell differentiation antigens, pp. 320-321, (1987)

[4]

Scott C.S., Limbert H.J., Jones R.A., Master P.S., Mackarill I.D., Patel D., Stark A.N., Immunological studies of B-cell leukaemias with particular reference to FMC7 and Tü1 (CD23) expression, Biotest Bulletin, 3, pp. 141-147, (1987)

[5]

Armitage R.J., Rowe D., Beverley P.C.L., McMichael A.M., Specificity and functional role of a monoclonal antibody 4B8 reactive with prolymphocytic leukaemia cells, Leucocyte typing III White cell differentiation antigens, pp. 500-502, (1987)

[6]

Rowe M., Hildreth J.E.K., Rickinson A.B., Epstein M.A., Monoclonal antibodies to Epstein-Barr virus-induced transformation-associated cell surface antigens: binding patterns and effect upon virus specific T-cell cytotoxicity, International Journal of Cancer, 29, pp. 373-381, (1982)

[7]

Kokai Y., Ishii Y., Kikuchi K., Characterization of two distinct antigens expressed on resting and activated human B cells as defined by monoclonal antibodies, Clinical and Experimental Immunology, 64, pp. 382-391, (1986)

[8]

Armitage R.J., Rowe D., Beverley P.C.L., A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B cells, European Journal of Immunology, 18, pp. 67-76, (1988)

[9]

Kersey J., Goldman A., Abramson C., Nesbit M., Perry G., Gajl-Peczalska K., Le Bien T., Clinical usefulness of monoclonal antibody phenotyping in childhood acute lymphoblastic leukaemia, Lancet, ii, pp. 1419-1423, (1982)

[10]

Ishii Y., Kokai Y., Yamaguchi H., Tsubola H., Kikuchi K., Surface marker expression in human B-cell lymphomas, AIDS Research, 2, pp. 587-593, (1986)

← 1 2 →